• 1
    Brandt LJ, Bjorkman D, Fennerty MB, et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002; 97: S726.
  • 2
    Inadomi JM, Fennerty MB, Bjorkman D. Systematic review: the economic impact of irritable bowel syndrome. Aliment Pharmacol Ther 2003; 18: 67182.
  • 3
    Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997; 112: 212037.
  • 4
    Sandler RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 1990; 99: 40915.
  • 5
    Maxion-Bergemann S, Thielecke F, Abel F, Bergemann R. Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics 2006; 24: 2137.
  • 6
    Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999; 45(Suppl. 2): II437.
  • 7
    Jellema P, van der Windt D, Schellevis FG, van der Horst HE. Systematic review: accuracy of symptom-based criteria for diagnosis of irritable bowel syndrome in primary care. Aliment Pharmacol Ther 2009; 30: 695706.
  • 8
    Khan S, Chang L. Diagnosis and management of IBS. Nat Rev Gastroenterol Hepatol 2010; 7: 56581.
  • 9
    Levy RL, Von Korff M, Whitehead WE, et al. Costs of care for irritable bowel syndrome patients in a health maintenance organization. Am J Gastroenterol 2001; 96: 31229.
    Direct Link:
  • 10
    Pare P, Gray J, Lam S, et al. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: Baseline results from LOGIC (longitudinal outcomes study of gastrointestinal symptoms in Canada), a naturalistic study. Clin Ther 2006; 28: 172635.
  • 11
    Hahn BA, Yan SK, Strassels S. Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion 1999; 60: 7781.
  • 12
    Drossman DA, Morris CB, Schneck S, et al. International survey of patients with IBS symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit. J Clin Gastroenterol 2009; 43: 54150.
  • 13
    Gralnek IM, Hays RD, Kilbourne AM, Chang L, Mayer EA. Racial differences in the impact of irritable bowel syndrome on health-related quality of life. J Clin Gastroenterol 2004; 38: 7829.
  • 14
    Park JM, Choi MG, Kim YS, et al. Quality of life of patients with irritable bowel syndrome in Korea. Qual Life Res 2009; 18: 43546.
  • 15
    Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000; 119: 65460.
  • 16
    Spiegel B, Harris L, Lucak S, et al. Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF cohort. Am J Gastroenterol 2009; 104: 198491.
  • 17
    Anonymous. American Gastroenterological Association medical position statement: irritable bowel syndrome. Gastroenterology 2002; 123: 21057.
  • 18
    Drossman D. Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gastroenterology 2003; 124: 75461.
  • 19
    Blanchard EB, Scharff L, Payne A, Schwarz SP, Suls JM, Malamood H. Prediction of outcome from cognitive behavioral treatment of irritable-bowel-syndrome. Behav Res Ther 1992; 30: 64750.
  • 20
    Blanchard EB, Lackner JM, Gusmano R, et al. Prediction of treatment outcome among patients with irritable bowel syndrome treated with group cognitive therapy. Behav Res Ther 2006; 44: 31737.
  • 21
    Koloski NA, Talley NJ, Boyce PM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol 2001; 96: 13409.
    Direct Link:
  • 22
    Donker GA, Foets M, Spreeuwenberg P. Patients with irritable bowel syndrome: health status and use of health care services. Br J Gen Pract 1999; 49: 78792.
  • 23
    Smart HL, Mayberry JF, Atkinson M. Alternative medicine consultations and remedies in patients with the irritable bowel syndrome. Gut 1986; 27: 8268.
  • 24
    Verhoef MJ, Sutherland LR, Brkich L. Use of alternative medicine by patients attending a gastroenterology clinic. CMAJ 1990; 142: 1215.
  • 25
    Spiegel BMR, Gralnek IM, Bolus R, et al. Clinical determinants of health-related quality of life in patients with irritable bowel syndrome. Arch Intern Med 2004; 164: 177380.
  • 26
    Spiegel B, Strickland A, Naliboff BD, Mayer EA, Chang L. Predictors of patient-assessed illness severity in irritable bowel syndrome. Am J Gastroenterol 2008; 103: 253643.
    Direct Link:
  • 27
    Labus JS, Mayer EA, Chang L, Bolus R, Naliboff BD. The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the Visceral Sensitivity Index. Psychosomatic Medicine 2007; 69: 8998.
  • 28
    Ballenger JC, Davidson JRT, Lecrubier Y, et al. Consensus statement on depression, anxiety, and functional gastrointestinal disorders. J Clin Psychiatry 2001; 62: 4851.
  • 29
    Murray CD, Flynn J, Ratcliffe L, Jacyna MR, Kamm MA, Emmanuel AV. Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome. Gastroenterology 2004; 127: 1695703.
  • 30
    Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut 1992; 33: 82530.
  • 31
    Bennett EJ, Piesse C, Palmer K, Badcock CA, Tennant CC, Kellow JE. Functional gastrointestinal disorders: psychological, social, and somatic features. Gut 1998; 42: 41420.
  • 32
    Bennett EJ, Tennant CC, Piesse C, Badcock CA, Kellow JE. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut 1998; 43: 25661.
  • 33
    Gibbs-Gallagher N, Palsson OS, Levy RL, Meyer K, Drossman DA, Whitehead WE. Selective recall of gastrointestinal-sensation words: evidence for a cognitive-behavioral contribution to irritable bowel syndrome. Am J Gastroenterol 2001; 96: 11338.
    Direct Link:
  • 34
    Gomborone JE, Dewsnap PA, Libby GW, Farthing MJ. Selective affective biasing in recognition memory in the irritable bowel syndrome. Gut 1993; 34: 12303.
  • 35
    Guthrie E, Creed F, Dawson D, Tomenson B. A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology 1991; 100: 4507.
  • 36
    Rumsey N. Group stress management programmes v pharmacological treatment in the treatment of the irritable bowel syndrome. In: HeatonKW, CreedF, GoetingNLM, eds. Current Approaches Toward Confident Management of Irritable Bowel Syndrome. Lyme Regis: Lyme Regis Printing, 1991.
  • 37
    Bennett P, Wilkinson S. A comparison of psychological and medical treatment of the irritable bowel syndrome. Br J Clin Psychol 1985; 24: 2156.
  • 38
    Heymann-Monnikes I, Arnold R, Florin I, Herda C, Melfsen S, Monnikes H. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 98194.
    Direct Link:
  • 39
    Blanchard EB, Greene B, Scharff L, Schwarzmcmorris SP. Relaxation training as a treatment for irritable-bowel-syndrome. Biofeed Self-Reg 1993; 18: 12532.
  • 40
    Lynch PM, Zamble E. A controlled behavioral treatment study of irritable bowel syndrome. Behav Ther 1989; 20: 50923.
  • 41
    Shaw G, Srivastava ED, Sadlier M, Swann P, James JY, Rhodes J. Stress management for irritable-bowel-syndrome – a controlled trial. Digestion 1991; 50: 3642.
  • 42
    Blanchard EB, Schwarz SP, Suls JM, et al. 2 Controlled evaluations of multicomponent psychological treatment of irritable-bowel-syndrome. Behav Res Ther 1992; 30: 17589.
  • 43
    Kabat-Zinn J. Commentary on Majumdar et al.: mindfulness meditation and health. J Altern Comp Med 2002; 8: 7315.
  • 44
    Baer RA. Mindfulness training as a clinical intervention: a conceptual and empirical review. Clin Psy: Sci Pract 2003; 10: 12543.
  • 45
    Baer RA, Smith GT, Lykins E, et al. Construct validity of the five facet mindfulness questionnaire in meditating and nonmeditating samples. Assessment 2008; 15: 32942.
  • 46
    Baer RA, Smith GT, Hopkins J, Krietemeyer J, Toney L. Using self-report assessment methods to explore facets of mindfulness. Assessment 2006; 13: 2745.
  • 47
    Ljotsson B, Falk L, Vesterlund AW, et al. Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome – a randomized controlled trial. Behav Res Ther 2010; 48: 5319.
  • 48
    Ljótsson B, Andréewitch S, Hedman E, Rück C, Andersson G, Lindefors N. Exposure and mindfulness based therapy for irritable bowel syndrome – an open pilot study. J Behav Ther Exp Psychiatry 2010; 41: 18590.
  • 49
    Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11: 395402.
  • 50
    Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci 1998; 43: 40011.
  • 51
    Labus JS, Bolus R, Chang L, et al. The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther 2004; 20: 8997.
  • 52
    Labus J, Mayer EA, Bolus R, Liu C, Olivas TI, Naliboff B. Gastrointestinal-specific anxiety: further validation of the visceral sensitivity index. Gastroenterology 2005; 128: A67.
  • 53
    Drossman D. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130: 137790.
  • 54
    Kazis LE, Ren XS, Lee A, et al. Health status in VA patients: results from the Veterans Health Study. Am J Med Qual 1999; 14: 2838.
  • 55
    Dobie DJ, Kivlahan DR, Maynard C, et al. Screening for post-traumatic stress disorder in female Veteran’s Affairs patients: validation of the PTSD checklist. Gen Hosp Psychiatry 2002; 24: 36774.
  • 56
    Walker EA, Newman E, Dobie DJ, Ciechanowski P, Katon W. Validation of the PTSD checklist in an HMO sample of women. Gen Hosp Psychiatry 2002; 24: 37580.
  • 57
    Ruggiero KJ, Del Ben K, Scotti JR, Rabalais AE. Psychometric properties of the PTSD checklist – Civilian version. J Trauma Stress 2003; 16: 495502.
  • 58
    Blanchard EB, JonesAlexander J, Buckley TC, Forneris CA. Psychometric properties of the PTSD checklist (PCL). Behav Res Ther 1996; 34: 66973.
  • 59
    Kabat-Zinn J. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results. Gen Hosp Psychiatry 1982; 4: 3347.
  • 60
    Shapiro SL, Carlson LE, Astin JA, Freedman B. Mechanisms of mindfulness. J Clin Psychol 2006; 62: 37386.
  • 61
    Segal ZV, Williams JMG, Teasdale JD. Mindfulness-Based Cognitive Therapy for Depression: A new Approach to Preventing Relapse. New York: Guilford Press, 2002.
  • 62
    Teasdale JD, Segal ZV, Williams JMG, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol 2000; 68: 61523.
  • 63
    Ljotsson B, Hedman E, Lindfors P, et al. Long-term follow-up of internet-delivered exposure and mindfulness based treatment for irritable bowel syndrome. Behav Res Ther 2011; 49: 5861.
  • 64
    Gaylord SA, Whitehead WE, Coble RS, et al. Mindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial. BMC Comp Altern Med 2009; 9: 24.